Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoît Stijlemans

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Immunobiology|May 30, 2017
Reprint of: The non-mammalian MIF superfamilyAmanda Sparkes, Patrick De Baetselier, Kim Roelants, et al.
Immunobiology|October 27, 2016
The non-mammalian MIF superfamilyAmanda Sparkes, Patrick De Baetselier, Kim Roelants, et al.
Journal of Immunological Methods|November 13, 2007
Parallel selection of multiple anti-infectome Nanobodies without access to purified antigensDirk Saerens, Benoît Stijlemans, Toya Nath Baral, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis-associated immunopathologyBenoît Stijlemans, Toya Nath Baral, Martin Guilliams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependentMichael B Drennan, Benoît Stijlemans, Jan Van den Abbeele, et al.
European Journal of Immunology|June 27, 2023
A few good reasons to use nanobodies for cancer treatmentNeema Ahishakiye Jumapili, Maida Zivalj, Romina Mora Barthelmess, et al.
Scientific Reports|August 1, 2015
E-cadherin expression in macrophages dampens their inflammatory responsiveness in vitro, but does not modulate M2-regulated pathologies in vivoJan Van den Bossche, Damya Laoui, Thomas Naessens, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2018
Novel half-life extended anti-MIF nanobodies protect against endotoxic shockAmanda Sparkes, Patrick De Baetselier, Lea Brys, et al.
Plos Pathogens|September 26, 2014
MIF contributes to Trypanosoma brucei associated immunopathogenicity developmentBenoît Stijlemans, Lin Leng, Lea Brys, et al.
Scientific Reports|July 27, 2018
Neutrophils enhance early Trypanosoma brucei infection onsetGuy Caljon, Dorien Mabille, Benoît Stijlemans, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Immunobiology|May 30, 2017
Reprint of: The non-mammalian MIF superfamilyAmanda Sparkes, Patrick De Baetselier, Kim Roelants, et al.
Immunobiology|October 27, 2016
The non-mammalian MIF superfamilyAmanda Sparkes, Patrick De Baetselier, Kim Roelants, et al.
Journal of Immunological Methods|November 13, 2007
Parallel selection of multiple anti-infectome Nanobodies without access to purified antigensDirk Saerens, Benoît Stijlemans, Toya Nath Baral, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis-associated immunopathologyBenoît Stijlemans, Toya Nath Baral, Martin Guilliams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependentMichael B Drennan, Benoît Stijlemans, Jan Van den Abbeele, et al.
European Journal of Immunology|June 27, 2023
A few good reasons to use nanobodies for cancer treatmentNeema Ahishakiye Jumapili, Maida Zivalj, Romina Mora Barthelmess, et al.
Scientific Reports|August 1, 2015
E-cadherin expression in macrophages dampens their inflammatory responsiveness in vitro, but does not modulate M2-regulated pathologies in vivoJan Van den Bossche, Damya Laoui, Thomas Naessens, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2018
Novel half-life extended anti-MIF nanobodies protect against endotoxic shockAmanda Sparkes, Patrick De Baetselier, Lea Brys, et al.
Plos Pathogens|September 26, 2014
MIF contributes to Trypanosoma brucei associated immunopathogenicity developmentBenoît Stijlemans, Lin Leng, Lea Brys, et al.
Scientific Reports|July 27, 2018
Neutrophils enhance early Trypanosoma brucei infection onsetGuy Caljon, Dorien Mabille, Benoît Stijlemans, et al.
Pageof 4